A PROPOSED DESIGN FOR A SIOP-E TRIAL IN OPTIC PATHWAY GLIOMA (OPG) ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 (NF1)

被引：0
|
作者：
Howman, Andrew [1 ]
Wheatley, Keith [1 ]
Walker, David [2 ]
Evans, Gareth [3 ]
Ferner, Rosalie [4 ]
Sehested, Astrid [5 ]
机构：
[1] Univ Birmingham, CRCTU, Birmingham, W Midlands, England
[2] Univ Nottingham, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England
[3] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Neurol, London, England
[5] Rigshosp, Dept Paediat Oncol, DK-2100 Copenhagen, Denmark
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1078 / 1078
页数：1
相关论文
共 50 条
  • [31] No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients
    Hutter, Sonja
    Piro, Rosario M.
    Waszak, Sebastian M.
    Kehrer-Sawatzki, Hildegard
    Friedrich, Reinhard E.
    Lassaletta, Alvaro
    Witt, Olaf
    Korbel, Jan O.
    Lichter, Peter
    Schuhmann, Martin U.
    Pfister, Stefan M.
    Tabori, Uri
    Mautner, Victor F.
    Jones, David T. W.
    HUMAN GENETICS, 2016, 135 (05) : 469 - 475
  • [32] NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1
    Toonen, Joseph A.
    Anastasaki, Corina
    Smithson, Laura J.
    Gianino, Scott M.
    Li, Kairong
    Kesterson, Robert A.
    Gutmann, David H.
    HUMAN MOLECULAR GENETICS, 2016, 25 (09) : 1703 - 1713
  • [33] 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma
    Anderson, David M. G.
    Van de Plas, Raf
    Rose, Kristie L.
    Hill, Salisha
    Schey, Kevin L.
    Solga, Anne C.
    Gutmann, David H.
    Caprioli, Richard M.
    JOURNAL OF PROTEOMICS, 2016, 149 : 77 - 84
  • [34] MEK-INHIBITOR MONOTHERAPY TO TREAT CONCURRENT OPTIC GLIOMA AND METASTATIC NEUROBLASTOMA IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
    Belsky, Jennifer
    Graham, Richard
    Leonard, Jeffery
    Finlay, Jonathan
    Jones, Jeremy
    Boue, Daniel
    Ranalli, Mark
    AbdelBaki, Mohamed
    NEURO-ONCOLOGY, 2018, 20 : 111 - 111
  • [35] Cardiovascular malformations in neurofibromatosis type 1 (NF1).
    Friedman, JM
    Birch, PH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A98 - A98
  • [36] Cutaneous haemangioma associated with a hepatic haemangioma and neurofibromatosis type 1 (NF1)
    Pascual-Castroviejo, I
    Cortes, P
    Fernandez-Cuadrado, J
    De la Flor-Crespo, M
    Pascual-Pascual, SI
    REVISTA DE NEUROLOGIA, 2002, 34 (07) : 652 - 654
  • [37] Mutation screening in neurofibromatosis type 1 (NF1)
    Park, VM
    Sturtevant, DB
    Kenwright, KA
    Pivnick, EK
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05): : 1652 - 1652
  • [38] Molecular genetics of neurofibromatosis type 1 (NF1)
    Shen, MH
    Harper, PS
    Upadhyaya, M
    JOURNAL OF MEDICAL GENETICS, 1996, 33 (01) : 2 - 17
  • [39] Choroidal Findings in Neurofibromatosis Type 1 (NF1)
    Giannini, Caterina
    Rodriguez, Fausto
    Eberhart, Charles
    Salomao, Diva
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 548 - 548
  • [40] Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
    Xu, Min
    Xiong, Hui
    Han, Yanfang
    Li, Chijun
    Mai, Shaozhen
    Huang, Zhongzhou
    Ai, Xuechen
    Guo, Zhixuan
    Zeng, Fanqin
    Guo, Qing
    FRONTIERS IN GENETICS, 2018, 9
12345